$ASST·8-K

Strive, Inc. · Jun 15, 6:01 AM ET

Compare

Strive, Inc. 8-K

Research Summary

AI-generated summary

Updated

Strive, Inc. Announces 13.00% Annual Dividend Rate on SATA Stock

What Happened

  • Strive, Inc. (ASST) announced on June 15, 2026 that its board maintained the regular annual dividend rate on the Company's SATA Stock at 13.00%, effective for periods commencing on or after July 1, 2026.
  • The board also declared daily cash dividends of $0.0493 per share of SATA Stock for each business day from July 1, 2026 through July 31, 2026 (22 business days), totaling $1.0846 per share for the full monthly period. Payments will be made to holders of record at the close of the immediately preceding business day.

Key Details

  • Annual dividend rate: 13.00% on SATA Stock (effective July 1, 2026).
  • Daily dividend: $0.0493 per SATA share for each business day in July 2026; aggregate $1.0846 for the month (22 business days).
  • Record/payment timing: daily payments made to stockholders of record as of the close of the prior business day; payment dates span July 1–31, 2026 per schedule in the filing.
  • Tax guidance: If distributions are not treated as coming from earnings and profits, U.S. investors receive a tax‑deferred return of capital to the extent of basis; non‑U.S. investors treated as exempt from U.S. dividend withholding tax. The Company states it does not have accumulated earnings and profits and does not expect current earnings and profits this year or foreseeable future.

Why It Matters

  • Income: SATA Stockholders will receive predictable daily cash payments in July amounting to a 13.00% annualized yield based on the declared rate.
  • Tax impact: Because Strive expects no earnings and profits, these distributions may be treated as a return of capital (not ordinary dividend) for U.S. investors, which reduces tax basis rather than creating immediate taxable income; non‑U.S. investors may be exempt from U.S. dividend withholding tax. Investors should consult a tax advisor for personal tax treatment.

Loading document...